Literature DB >> 3107042

L-dopa causes an acute, partial and reversible reversal of denervation-induced supersensitivity of striatal dopaminergic receptors.

S Ferre, M Casas, A Cobos, C Garcia, F Jane, J M Grau.   

Abstract

Denervation-induced supersensitivity of the striatal dopamine receptors can be quantified by the turning behaviour induced by apomorphine. With this experimental model we found that high-dose L-dopa/carbidopa administration reduced this supersensitivity. This effect was seen on the 1st day and did not alter over 5 or 10 days of treatment, but disappeared when medication was discontinued. The degree of reduction was the same, independent of the dose and period of administration. This effect could provide a useful model for studying the phenomenon of the irreversibility of the supersensitivity of the striatal dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107042     DOI: 10.1007/bf00217074

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

Review 1.  Hormonal regulation of peptide receptors and target cell responses.

Authors:  K J Catt; J P Harwood; G Aguilera; M L Dufau
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

2.  Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.

Authors:  M Herrera-Marschitz; C Forster; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1985-11

3.  Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

Authors:  T Lee; P Seeman; A Rajput; I J Farley; O Hornykiewicz
Journal:  Nature       Date:  1978-05-04       Impact factor: 49.962

4.  Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.

Authors:  M Suga
Journal:  Life Sci       Date:  1980-09-08       Impact factor: 5.037

5.  Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.

Authors:  S J List; P Seeman
Journal:  Life Sci       Date:  1979-04-16       Impact factor: 5.037

6.  Presynaptic subsensitivity as a possible basis for sensitization by long-term dopamine mimetics.

Authors:  P Muller; P Seeman
Journal:  Eur J Pharmacol       Date:  1979-04-15       Impact factor: 4.432

7.  The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.

Authors:  M Globus; J Bannet; B Lerer; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.

Authors:  R Castro; P Abreu; C H Calzadilla; M Rodriguez
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Reversal of two manifestations of dopamine receptor supersensitivity by administration of L-dopa.

Authors:  A J Friedhoff; K Bonnet; H Tosengarten
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-03

10.  Dopamine D2 receptor density remains constant in treated Parkinson's disease.

Authors:  M Guttman; P Seeman; G P Reynolds; P Riederer; K Jellinger; W W Tourtellotte
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.